FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kevin Bliden

Research Profile

Chemicals & Drugs

Physiology

Devices

Stents

Disorders

Coronary Artery Disease

Anatomy

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Kevin P Bliden; William L Bailey; Brian A Baker; Young-Hoon Jeong; Thomas D Nolin; Udaya S Tantry; Paul A Gurbel
Thienopyridine efficacy and cigarette smoking status.
Kristopher J Swiger; Udaya S Tantry; Omair Yousuf; Kevin P Bliden; Paul A Gurbel
Cigarette smoking and clopidogrel interaction.
Joshua P Lewis; Braxton D Mitchell; Jeffrey R O'Connell; Ruth Pakzy; Afshin Parsa; Carl J Pepine; Toni I Pollin; Wendy S Post; Kathleen Ryan; Amber L Beitelshees; Kevin P Bliden; Coleen M Damcott; Nauder Faraday; Quince Gibson; Yan Gong; Paul A Gurbel; William Herzog; Richard B Horenstein; Julie A Johnson; Keith Tanner; Udaya S Tantry; Alan R Shuldiner
Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kevin Bliden (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kevin P Bliden; William L Bailey; Brian A Baker; Young-Hoon Jeong; Thomas D Nolin; Udaya S Tantry; Paul A Gurbel
Thienopyridine efficacy and cigarette smoking status.
American heart journal 2013;165(5):693-703.
2013: Kristopher J Swiger; Udaya S Tantry; Omair Yousuf; Kevin P Bliden; Paul A Gurbel
Cigarette smoking and clopidogrel interaction.
Current cardiology reports 2013;15(5):361.
2013: Joshua P Lewis; Braxton D Mitchell; Jeffrey R O'Connell; Ruth Pakzy; Afshin Parsa; Carl J Pepine; Toni I Pollin; Wendy S Post; Kathleen Ryan; Amber L Beitelshees; Kevin P Bliden; Coleen M Damcott; Nauder Faraday; Quince Gibson; Yan Gong; Paul A Gurbel; William Herzog; Richard B Horenstein; Julie A Johnson; Keith Tanner; Udaya S Tantry; Alan R Shuldiner
Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomes.
Circulation. Cardiovascular genetics 2013;6(2):184-92.
2013: Paul A Gurbel; Young-Hoon Jeong; Alan R Shuldiner; Mark Antonino; Kevin P Bliden; Sumbul Chai; John G Fort; Martin Gesheff; Tania Gesheff; Ying Zhang; Udaya S Tantry
Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel.
American heart journal 2013;165(2):176-82.
2013: Joshua P Lewis; Braxton D Mitchell; Jeffrey R O'Connell; Michael A Pacanowski; Cody J Peer; Kathleen Ryan; Kevin P Bliden; Sumbul Chai; William D Figg; Quince Gibson; Paul A Gurbel; Richard B Horenstein; Shawn D Spencer; Keith Tanner; Udaya S Tantry; Alan R Shuldiner
The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response.
Pharmacogenetics and genomics 2013;23(1):1-8.
2013: Anand Singla; Udaya S Tantry; Young-Hoon Jeong; Denny P Mathew; William C Muse; Katrina Abadilla; Mark J Antonino; Oscar Bailon; Kevin P Bliden; Paul A Gurbel
Platelet reactivity and thrombogenicity in postmenopausal women.
Menopause (New York, N.Y.) 2013;20(1):57-63.
2013: Young-Hoon Jeong; Udaya S Tantry; Mark J Antonino; Kevin P Bliden; Paul A Gurbel
Usefulness of thrombelastography platelet mapping assay to measure the antiplatelet effect of P2Y(12) receptor inhibitors and high on-treatment platelet reactivity.
Platelets 2013;24(2):166-9.
2012: Young-Hoon Jeong; Sunjoo Kim; Eun-Ha Koh; Choong Hwan Kwak; Tae Jung Kwon; Jeong Rang Park; Yongwhi Park; Udaya S Tantry; Kevin P Bliden; Jin-Yong Hwang; Seok-Jae Hwang; Paul A Gurbel
Pharmacodynamic effect of cilostazol plus standard clopidogrel versus double-dose clopidogrel in patients with type 2 diabetes undergoing percutaneous coronary intervention.
Diabetes care 2012;35(11):2194-7.
2012: Yongwhi Park; Udaya S Tantry; Jong Hwa Ahn; Kevin P Bliden; Eun-Ha Gho; Jin-Yong Hwang; Seok-Jae Hwang; Young-Hoon Jeong; Sunjoo Kim; Choong Hwan Kwak; Tae Jung Kwon; Jeong Rang Park; Paul A Gurbel
Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study.
European heart journal 2012;33(17):2151-62.
2012: Young-Hoon Jeong; Yongwhi Park; Udaya S Tantry; Kevin P Bliden; Paul A Gurbel
Pharmacogenetic guidance for antiplatelet treatment.
Lancet 2012;380(9843):725; author reply 725-6.
2012: Mark J Antonino; Kevin P Bliden; Young-Hoon Jeong; Udaya S Tantry; Paul A Gurbel
Role of genotype-based personalized antiplatelet therapy in the era of potent P2Y₁₂ receptor inhibitors.
Expert review of cardiovascular therapy 2012;10(8):1011-22.
2012: Young-Hoon Jeong; Ki-Soo Park; Udaya S Tantry; Mark J Antonino; Kevin P Bliden; Paul A Gurbel
Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapies.
American heart journal 2012;164(1):35-42.
2012: Elisabeth Mahla; Helfried Metzler; Peter Rehak; Jeffery Sell; Alejandro J Sequeira; Thomas A Suarez; Udaya S Tantry; Mark J Antonino; Kevin P Bliden; Peter Cho; John Fan; Paul A Gurbel
Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study.
Circulation. Cardiovascular interventions 2012;5(2):261-9.
2012: Young-Hoon Jeong; Udaya S Tantry; Kevin P Bliden; Paul A Gurbel
High on-treatment platelet reactivity assessed by various platelet function tests: is the consensus-defined cut-off of VASP-P platelet reactivity index too low?
Journal of thrombosis and haemostasis : JTH 2012;10(3):487-9.
2012: Young-Hoon Jeong; Yongwhi Park; Udaya S Tantry; Kevin P Bliden; Paul A Gurbel
High platelet reactivity to multiple agonists during aspirin and clopidogrel treatment is indicative of a global hyperreactive platelet phenotype.
Heart (British Cardiac Society) 2012;98(4):343; author reply 343-4.
2012: Jacek Kubica; Eliano P Navarese; Udaya S Tantry; Iwona Świątkiewicz; Kevin P Bliden; Tomasz Fabiszak; Grzegorz Grześk; Marek Koziński; Aldona Kubica; Paul A Gurbel
Updated evidence on intracoronary abciximab in ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized clinical trials.
Cardiology journal 2012;19(3):230-42.
2011: Paul A Gurbel; J R Plachetka; Y Zhang; M Antonino; Kevin P Bliden; J Fort; M Gesheff; Udaya S Tantry
Pharmacodynamic evaluation of clopidogrel plus PA32540: the Spaced PA32540 With Clopidogrel Interaction Gauging (SPACING) study.
Clinical pharmacology and therapeutics 2011;90(6):860-6.
2011: J P Lewis; Braxton D Mitchell; Jeffrey R O'Connell; R Pakzy; K Ryan; Haiqing Shen; Kevin P Bliden; A S Fisch; Q Gibson; Paul A Gurbel; Richard B Horenstein; K Tanner; Udaya S Tantry; Alan R Shuldiner
Paraoxonase 1 (PON1) gene variants are not associated with clopidogrel response.
Clinical pharmacology and therapeutics 2011;90(4):568-74.
2011: R F Storey; U Tantry; C Wei; A Karunakaran; Kevin P Bliden; K Butler; R Ecob; Paul A Gurbel
Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responses.
Journal of thrombosis and haemostasis : JTH 2011;9(9):1730-7.
2011: Young-Hoon Jeong; In-Suk Kim; Yongwhi Park; Udaya S Tantry; Kevin P Bliden; Paul A Gurbel
We need further studies for the development of "optimized antiplatelet therapy" based on ethnicity.
Journal of the American College of Cardiology 2011;58(2):198; author reply 198-9.
2011: Kevin P Bliden; Martin Gesheff; Young-Hoon Jeong; Robert F Storey; Udaya S Tantry; Cheryl Wei; Paul A Gurbel
The effect of ticagrelor versus clopidogrel on high on-treatment platelet reactivity: combined analysis of the ONSET/OFFSET and RESPOND studies.
American heart journal 2011;162(1):160-5.
2011: Young-Hoon Jeong; Udaya S Tantry; Kevin P Bliden; Paul A Gurbel
Do East Asians have different hypercoagulable states compared with Western population?
American heart journal 2011;162(1):e19-20; author reply e21-2.
2011: Kevin P Bliden; Udaya S Tantry; Joseph DiChiara; Paul A Gurbel
Further ex vivo evidence supporting higher aspirin dosing in patients with coronary artery disease and diabetes.
Circulation. Cardiovascular interventions 2011;4(2):118-20.
2011: Paul A Gurbel; Alan R Shuldiner; Kevin P Bliden; Kathaleen Ryan; Ruth E Pakyz; Udaya S Tantry
The relation between CYP2C19 genotype and phenotype in stented patients on maintenance dual antiplatelet therapy.
American heart journal 2011;161(3):598-604.
2011: Young-Hoon Jeong; Udaya S Tantry; Kevin P Bliden; Paul A Gurbel
Cilostazol to overcome high on-treatment platelet reactivity in korean patients treated with clopidogrel and calcium-channel blocker.
Circulation journal : official journal of the Japanese Circulation Society 2011;75(11):2534-6.
2010: Udaya S Tantry; Kevin P Bliden; Cheryl Wei; Robert F Storey; Martin Armstrong; Kathleen Butler; Paul A Gurbel
First analysis of the relation between CYP2C19 genotype and pharmacodynamics in patients treated with ticagrelor versus clopidogrel: the ONSET/OFFSET and RESPOND genotype studies.
Circulation. Cardiovascular genetics 2010;3(6):556-66.
2010: Mark J Antonino; Rosa Coppolecchia; Elisabeth Mahla; Kevin P Bliden; Udaya S Tantry; Paul A Gurbel
Antiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin alone.
Thrombosis research 2010;126(5):384-5.
2010: Paul A Gurbel; Kevin P Bliden; Irene A Navickas; Elizabeth Mahla; Joseph DiChiara; Thomas A Suarez; Mark J Antonino; Udaya S Tantry; Eli Cohen
Adenosine diphosphate-induced platelet-fibrin clot strength: a new thrombelastographic indicator of long-term poststenting ischemic events.
American heart journal 2010;160(2):346-54.
2010: Robert F Storey; Kevin P Bliden; Shankar B Patil; Arun Karunakaran; Rosemary Ecob; Kathleen Butler; Renli Teng; Cheryl Wei; Udaya S Tantry; Paul A Gurbel
Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET/OFFSET study.
Journal of the American College of Cardiology 2010;56(3):185-93.
2010: Paul A Gurbel; Kevin P Bliden; Kathleen Butler; Mark J Antonino; Cheryl Wei; Renli Teng; Lars Rasmussen; Robert F Storey; Tonny Nielsen; John W Eikelboom; Georges Sabe-Affaki; Steen Husted; Dean J Kereiakes; David Henderson; Dharmendra V Patel; Udaya S Tantry
Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study.
Circulation 2010;121(10):1188-99.
2010: Udaya S Tantry; Kevin P Bliden; Thomas A Suarez; Rolf P Kreutz; Joseph DiChiara; Paul A Gurbel
Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: results of the Thrombotic RIsk Progression (TRIP) study.
Platelets 2010;21(5):360-7.
2010: Paul A Gurbel; Kevin P Bliden; M J Antonino; G Stephens; D D Gretler; M M Jurek; R E Pakyz; Alan R Shuldiner; P B Conley; Udaya S Tantry
The effect of elinogrel on high platelet reactivity during dual antiplatelet therapy and the relation to CYP2C19*2 genotype: first experience in patients.
Journal of thrombosis and haemostasis : JTH 2010;8(1):43-53.
2009: Paul A Gurbel; Kevin P Bliden; Kathleen Butler; Udaya S Tantry; Tania Gesheff; Cheryl Wei; Renli Teng; Mark J Antonino; Shankar B Patil; Arun Karunakaran; Dean J Kereiakes; Cordel Parris; Drew Purdy; Vance Wilson; Gary S Ledley; Robert F Storey
Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study.
Circulation 2009;120(25):2577-85.
2009: Anand Singla; Mark J Antonino; Kevin P Bliden; Udaya S Tantry; Paul A Gurbel
The relation between platelet reactivity and glycemic control in diabetic patients with cardiovascular disease on maintenance aspirin and clopidogrel therapy.
American heart journal 2009;158(5):784.e1-6.
2009: Alan R Shuldiner; Jeffrey R O'Connell; Kevin P Bliden; Amish Gandhi; Kathleen Ryan; Richard B Horenstein; Coleen M Damcott; Ruth Pakyz; Udaya S Tantry; Quince Gibson; Toni I Pollin; Wendy S Post; Afshin Parsa; Braxton D Mitchell; Nauder Faraday; WILLIAM HERZOG; Paul A Gurbel
Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy.
JAMA : the journal of the American Medical Association 2009;302(8):849-57.
2009: Mark J Antonino; Elisabeth Mahla; Kevin P Bliden; Udaya S Tantry; Paul A Gurbel
Effect of long-term clopidogrel treatment on platelet function and inflammation in patients undergoing coronary arterial stenting.
The American journal of cardiology 2009;103(11):1546-50.
2009: Paul A Gurbel; Kevin P Bliden; Rolf P Kreutz; Joseph DiChiara; Mark J Antonino; Udaya S Tantry
The link between heightened thrombogenicity and inflammation: pre-procedure characterization of the patient at high risk for recurrent events after stenting.
Platelets 2009;20(2):97-104.
2009: Paul A Gurbel; Kevin P Bliden; Jorge F Saucedo; Thomas A Suarez; Joseph DiChiara; Mark J Antonino; Elisabeth Mahla; Anand Singla; WILLIAM HERZOG; Ashwani K Bassi; Thomas A Hennebry; Tania B Gesheff; Udaya S Tantry
Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (Clopidogrel with Eptifibatide to Arrest the Reactivity of Platelets) study.
Journal of the American College of Cardiology 2009;53(8):648-57.
2008: Paul A Gurbel; Mark J Antonino; Kevin P Bliden; Joseph Dichiara; Thomas A Suarez; Anand Singla; Udaya S Tantry
Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target.
Platelets 2008;19(8):595-604.
2008: Miruais S Hamed; Steven Gambert; Kevin P Bliden; Oscar Bailon; Anand Singla; Singla Anand; Mark J Antonino; Fatema Hamed; Udaya S Tantry; Paul A Gurbel
Dark chocolate effect on platelet activity, C-reactive protein and lipid profile: a pilot study.
Southern medical journal 2008;101(12):1203-8.
2008: Kevin P Bliden; Joseph DiChiara; Lookman Lawal; Anand Singla; Mark J Antonino; Brian A Baker; William L Bailey; Udaya S Tantry; Paul A Gurbel
The association of cigarette smoking with enhanced platelet inhibition by clopidogrel.
Journal of the American College of Cardiology 2008;52(7):531-3.
2008: Paul A Gurbel; Kevin P Bliden; Eli Cohen; Irene A Navickas; Anand Singla; Mark J Antonino; Mulugeta Fissha; Rolf P Kreutz; Ashwani K Bassi; Udaya S Tantry
Race and sex differences in thrombogenicity: risk of ischemic events following coronary stenting.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2008;19(4):268-75.
2008: Paul A Gurbel; Rolf P Kreutz; Kevin P Bliden; Joseph DiChiara; Udaya S Tantry
Biomarker analysis by fluorokine multianalyte profiling distinguishes patients requiring intervention from patients with long-term quiescent coronary artery disease: a potential approach to identify atherosclerotic disease progression.
American heart journal 2008;155(1):56-61.
2007: Rolf P Kreutz; Udaya S Tantry; Kevin P Bliden; Paul A Gurbel
Inflammatory changes during the 'common cold' are associated with platelet activation and increased reactivity of platelets to agonists.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007;18(8):713-8.
2007: Joseph DiChiara; Kevin P Bliden; Udaya S Tantry; Miruais S Hamed; Mark J Antonino; Thomas A Suarez; Oscar Bailon; Anand Singla; Paul A Gurbel
The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study.
Diabetes 2007;56(12):3014-9.
2007: Paul A Gurbel; Kevin P Bliden; I Navickas; E Cohen; Udaya S Tantry
Post-coronary intervention recurrent ischemia in the presence of adequate platelet inhibition by dual antiplatelet therapy: what are we overlooking?
Journal of thrombosis and haemostasis : JTH 2007;5(11):2300-1.
2007: Joseph DiChiara; Kevin P Bliden; Udaya S Tantry; Srivasavi K Chaganti; Rolf P Kreutz; Tania B Gesheff; Yvonne Kreutz; Paul A Gurbel
Platelet function measured by VerifyNow identifies generalized high platelet reactivity in aspirin treated patients.
Platelets 2007;18(6):414-23.
2007: Paul A Gurbel; Kevin P Bliden; Joseph DiChiara; Justin Newcomer; Willy Weng; Nagaraj K Neerchal; Tania Gesheff; Srivasavi K Chaganti; Amena Etherington; Udaya S Tantry
Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Circulation 2007;115(25):3156-64.
2007: Paul A Gurbel; Kevin P Bliden; Udaya S Tantry
Evidence that pre-existent variability in platelet response to ADP accounts for 'clopidogrel resistance': a rebuttal.
Journal of thrombosis and haemostasis : JTH 2007;5(5):1087-8; author reply 1089-90.
2007: Kevin P Bliden; Joseph DiChiara; Udaya S Tantry; Ashwani K Bassi; Srivasavi K Chaganti; Paul A Gurbel
Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?
Journal of the American College of Cardiology 2007;49(6):657-66.
2007: Udaya S Tantry; Kevin P Bliden; Paul A Gurbel
AZD6140.
Expert opinion on investigational drugs 2007;16(2):225-9.
2007: Paul A Gurbel; Kevin P Bliden; Amena Etherington; Udaya S Tantry
Assessment of clopidogrel responsiveness: measurements of maximum platelet aggregation, final platelet aggregation and their correlation with vasodilator-stimulated phosphoprotein in resistant patients.
Thrombosis research 2007;121(1):107-15.
2007: Paul A Gurbel; Kevin P Bliden; Kirk Guyer; Nikhil Aggarwal; Udaya S Tantry
Delayed thrombin-induced platelet-fibrin clot generation by clopidogrel: a new dose-related effect demonstrated by thrombelastography in patients undergoing coronary artery stenting.
Thrombosis research 2007;119(5):563-70.
2006: Paul A Gurbel; Kevin P Bliden; Udaya S Tantry
Effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting: results from the CLEAR PLATELETS 1b study.
Journal of the American College of Cardiology 2006;48(11):2186-91.
2006: Udaya S Tantry; Kevin P Bliden; Paul A Gurbel
Prasugrel.
Expert opinion on investigational drugs 2006;15(12):1627-33.
2006: Udaya S Tantry; Amena Etherington; Kevin P Bliden; Paul A Gurbel
Antiplatelet therapy: current strategies and future trends.
Future cardiology 2006;2(3):343-66.
2006: Barry E Bleske; John M Nicklas; Robert L Bard; Robert D Brook; Paul A Gurbel; Kevin P Bliden; Sanjay Rajagopalan; Bertram Pitt
Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level.
Journal of the American College of Cardiology 2006;47(2):338-41.
2006: Paul A Gurbel; Wei C Lau; Kevin P Bliden; Udaya S Tantry
Clopidogrel resistance: implications for coronary stenting.
Current pharmaceutical design 2006;12(10):1261-9.
2005: Udaya S Tantry; Kevin P Bliden; Paul A Gurbel
What is the best measure of thrombotic risks--pretreatment platelet aggregation, clopidogrel responsiveness, or posttreatment platelet aggregation?
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2005;66(4):597-8.
2005: Paul A Gurbel; Kevin P Bliden; Waiel M Samara; Jason A Yoho; Kevin Hayes; Mulugeta Fissha; Udaya S Tantry
Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study.
Journal of the American College of Cardiology 2005;46(10):1827-32.
2005: Paul A Gurbel; Kevin P Bliden; Kirk Guyer; Peter W Cho; Kazi A Zaman; Rolf P Kreutz; Ashwani K Bassi; Udaya S Tantry
Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study.
Journal of the American College of Cardiology 2005;46(10):1820-6.
2005: Udaya S Tantry; Kevin P Bliden; Paul A Gurbel
Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation.
Journal of the American College of Cardiology 2005;46(9):1705-9.
2005: Udaya S Tantry; Kevin P Bliden; Paul A Gurbel
Resistance to antiplatelet drugs: current status and future research.
Expert opinion on pharmacotherapy 2005;6(12):2027-45.
2005: Rolf P Kreutz; Kevin P Bliden; Udaya S Tantry; Paul A Gurbel
Viral respiratory tract infections increase platelet reactivity and activation: an explanation for the higher rates of myocardial infarction and stroke during viral illness.
Journal of thrombosis and haemostasis : JTH 2005;3(9):2108-9.
2005: Paul A Gurbel; Kevin P Bliden; Kevin M Hayes; Jason A Yoho; WILLIAM HERZOG; Udaya S Tantry
The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting.
Journal of the American College of Cardiology 2005;45(9):1392-6.
2005: Paul A Gurbel; Kevin P Bliden; Kazi A Zaman; Jason A Yoho; Kevin M Hayes; Udaya S Tantry
Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study.
Circulation 2005;111(9):1153-9.
2005: Paul A Gurbel; Kevin Hayes; Kevin P Bliden; Jason A Yoho; Udaya S Tantry
The platelet-related effects of tenecteplase versus alteplase versus reteplase.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2005;16(1):1-7.
2005: Waiel M Samara; Kevin P Bliden; Udaya S Tantry; Paul A Gurbel
The difference between clopidogrel responsiveness and posttreatment platelet reactivity.
Thrombosis research 2005;115(1-2):89-94.
2004: Paul A Gurbel; Kevin P Bliden; Kevin M Hayes; Udaya S Tantry
Platelet activation in myocardial ischemic syndromes.
Expert review of cardiovascular therapy 2004;2(4):535-45.
2004: Paul A Gurbel; Waiel M Samara; Kevin P Bliden
Failure of clopidogrel to reduce platelet reactivity and activation following standard dosing in elective stenting: implications for thrombotic events and restenosis.
Platelets 2004;15(2):95-9.
2003: Paul A Gurbel; Kevin P Bliden
A new method of representing drug-induced platelet inhibition: better description of time course, response variability, non-response, and heightened activity.
Platelets 2003;14(7-8):481-3.
2003: Paul A Gurbel; Kevin P Bliden
Platelet activation after stenting with heparin-coated versus noncoated stents.
American heart journal 2003;146(4):E10.
2003: Paul A Gurbel; Kevin P Bliden; Bonnie L Hiatt; Christopher M O'Connor
Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity.
Circulation 2003;107(23):2908-13.
2003: Paul A Gurbel; Kevin P Bliden; B L Hiatt
The early antiplatelet effects of clopidogrel loading for coronary stenting and the long-term stability of inhibition.
Journal of thrombosis and haemostasis : JTH 2003;1(6):1319-21.
2003: Paul A Gurbel; Kevin P Bliden
Durability of platelet inhibition by clopidogrel.
The American journal of cardiology 2003;91(9):1123-5.
2003: Paul A Gurbel; Kevin P Bliden
The stratification of platelet reactivity and activation in patients with stable coronary artery disease on aspirin therapy.
Thrombosis research 2003;112(1-2):9-12.
2002: Paul A Gurbel; Brian Galbut; Kevin P Bliden; Raymond D Bahr; Matthew T Roe; Victor L Serebruany; W Brian Gibler; Robert H Christenson; Erik Ohman
Effect of eptifibatide for acute coronary syndromes: rapid versus late administration--therapeutic yield on platelets (The EARLY Platelet Substudy).
Journal of thrombosis and thrombolysis 2002;14(3):213-9.